According to Daljeet Kohli, there is no question on the fundamentals or the long-term growth of LIC Housing Finance. Valuation is cheap and in buyers favour and so, one should be buying this stock.
Daljeet Kohli of India-Nivesh Securities is of the view that Cadila Healthcare may test Rs 913. "This is a story for another 1-1.5 years where we will see the company going back to the normal trajectory of 20 plus margins and that will result in re-rating of the stock," Kohli said.
Daljeet Kohli of India-Nivesh Securities is of the view that Oil India may touch Rs 672 and feels that Aditya Birla Nuvo may touch Rs 1506.
Daljeet Kohli of India-Nivesh Securities is of the view that UPL may test Rs 217. "The company is well diversified, it is available in 40 countries across the world," he reasoned.
Daljeet Kohli of India-Nivesh Securities is of the view that Coromandel International may touch Rs 279.
Daljeet Kohli of India-Nivesh Securities recommends buying LIC Housing Finance. "Valuation of the stock is cheap and in one's favour," he adds.
Daljeet Kohli, Head of Research at IndiaNivesh Securities Private Limited advised booking profits in Ranbaxy Labs.
Daljeet Kohli, Head of Research at IndiaNivesh Securities Private Limited said one had to be with HDFC in financial space. “HDFC has been the most consistent performer,†he added.
Daljeet Kohli, Head of Research at IndiaNivesh Securities Private Limited said he would prefer LIC Housing or GIC Housing over Dewan Housing.
The January-March quarter earnings season has entered into the fourth week and several top corporates have already reported their earnings. However, not many have satisfied the street and there have been several ratings downgrades.